Sep 17 2021
A research team led by Associate Professor DOMON Hisanori and Professor TERAO Yutaka in the Division of Microbiology and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, discovered that clarithromycin, a macrolide antibiotics*, suppresses the release of pneumococcal toxins and would prevent the aggravation of pneumonia. The team aims to develop new therapeutic agents for pneumonia based on this research. The results of this research were published electronically on September 1, 2021 in Microbiology Spectrum, the American Society for Microbiology journal.
* Macrolide antibiotics: An antibacterial drug due to suppressing bacterial protein synthesis
Journal: Microbiology Spectrum
Title: Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation
Authors: Hisanori Domon, Toshihito Isono, Takumi Hiyoshi, Hikaru Tamura, Karin Sasagawa, Tomoki Maekawa, Satoru Hirayama, Katsunori Yanagihara, Yutaka Terao
DOI: 10.1128/Spectrum.00318-21
Discovery of a New Pathology for Spinal Hypertrophic Pachymeningitis Caused by Vasculitides, Designated an Intractable Disease by the Ministry of Health, Labor and Welfare, Japan: A Path to Therapy
"Chocolate Chip Sign" on Susceptibility-Weighted Imaging: A Novel Neuroimaging Biomarker for HTRA1-Related Cerebral Small Vessel Disease
Eye Pupils Dilate Slightly When Viewing a Memorable Photo